Gabriel Cerrone insider trades: Synergy Pharmaceuticals (SGYP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gabriel reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 29, 2013 | SGYP | ↑ Buy | 12,000 | $4.09 | $49K | By Panetta Partners, Ltd. | Oct 29, 2013 (0d) |
| Jun 14, 2013 | SGYP | ↑ Buy | 8,000 | $4.42 | $35K | By Panetta Partners, Ltd. | Jun 14, 2013 (0d) |
| Apr 24, 2013 | SGYP | ↑ Buy | 12,500 | $4.46 | $56K | By Panetta Partners, Ltd. | Apr 24, 2013 (0d) |
| Apr 24, 2013 | SGYP | ↑ Buy | 5,500 | $4.66 | $26K | By Panetta Partners, Ltd. | Apr 24, 2013 (0d) |
| Feb 5, 2013 | SGYP | ↑ Buy | 5,000 | $6.15 | $31K | By Panetta Partners, Ltd. | Feb 5, 2013 (0d) |
| Feb 4, 2013 | SGYP | ↑ Buy | 13,090 | $6.04 | $79K | By Panetta Partners, Ltd. | Feb 4, 2013 (0d) |
| Nov 14, 2012 | SGYP | ↑ Buy | 87,820 | $3.61 | $317K | By Panetta Partners Ltd. | Nov 15, 2012 (1d) |
| Aug 20, 2012 | TROV | ↑ Buy | 7,800 | $2.35 | $18K | By Panetta Partners, Ltd. | Aug 20, 2012 (0d) |
| Aug 16, 2012 | TROV | ↑ Buy | 15,000 | $2.24 | $34K | By Panetta Partners, Ltd. | Aug 17, 2012 (1d) |
| Apr 13, 2012 | TROV | ↑ Buy | 200,000 | $0.50 | $100K | By Panetta Partners Ltd. | Apr 16, 2012 (3d) |
| Nov 14, 2011 | SGYP | ↑ Buy | 470,588 | $2.13 | $1000K | By Panetta Partners, Ltd. | Nov 15, 2011 (1d) |
| Jun 9, 2005 | KAL | ↑ Buy | 5,000 | $1.00 | $5K | By Panetta Partners, Ltd. | Jun 13, 2005 (4d) |
| Jun 3, 2005 | KAL | ↑ Buy | 6,000 | $1.02 | $6K | By Panetta Partners, Ltd. | Jun 6, 2005 (3d) |
| May 27, 2005 | KAL | ↑ Buy | 8,000 | $1.00 | $8K | By Panetta Partners, Ltd. | Jun 1, 2005 (5d) |
| May 19, 2005 | KAL | ↑ Buy | 12,500 | $1.02 | $13K | By Panetta Partners, Ltd. | May 23, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gabriel Cerrone's insider trades
Gabriel Cerrone is an insider at Synergy Pharmaceuticals (SGYP). Since May 19, 2005, Gabriel has reported 15 open-market purchases worth $1.8M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (18 filings), other transactions (7 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGYP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.